![](https://webarchive.library.unt.edu/eot2008/20081025022755im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081025022755im_/http://www.cancer.gov/images/spacer.gif)
CB10-277 A synthetic derivative of dimethylphenyl-triazene related to dacarbazine, with antineoplastic properties. Related to the agent dacarbazine, CB10-277 is converted in vivo to a monomethyl triazene form that alkylates DNA, resulting in inhibition of DNA replication and repair; in addition, this agent may act as a purine analogue, resulting in inhibition of DNA synthesis, and may interact with protein sulfhydryl groups. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
![](https://webarchive.library.unt.edu/eot2008/20081025022755im_/http://www.cancer.gov/images/spacer.gif)
Chemical structure name: | ![](https://webarchive.library.unt.edu/eot2008/20081025022755im_/http://www.cancer.gov/images/spacer.gif) | 1-p-carboxy-3,3-dimethylphenyltriazine | | ![](https://webarchive.library.unt.edu/eot2008/20081025022755im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081025022755im_/http://www.cancer.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081025022755im_/http://www.cancer.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081025022755im_/http://www.cancer.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/eot2008/20081025022755im_/http://www.cancer.gov/images/spacer.gif) |